Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
128409017 | Dihydrouracil dehydrogenase (NADP^+^) deficiency | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
128410010 | Dihydropyrimidine dehydrogenase deficiency | en | Synonym | Active | Case insensitive | SNOMED CT core |
128411014 | Dihydrothymine dehydrogenase deficiency | en | Synonym | Active | Case insensitive | SNOMED CT core |
128412019 | Sensitivity to fluorouracil toxicity | en | Synonym | Active | Case insensitive | SNOMED CT core |
128413012 | Hereditary thymine-uraciluria | en | Synonym | Active | Case insensitive | SNOMED CT core |
128414018 | Familial pyrimidinemia | en | Synonym | Active | Case insensitive | SNOMED CT core |
2974381011 | Dihydrouracil dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) deficiency | en | Synonym | Active | Case insensitive | SNOMED CT core |
4964974019 | Dihydropyrimidine dehydrogenase deficiency (disorder) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4964975018 | DPD - dihydropyrimidine dehydrogenase deficiency | en | Synonym | Active | Case sensitive | SNOMED CT core |
503535019 | Dihydrouracil dehydrogenase (NADP) deficiency | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
503536018 | Familial pyrimidinaemia | en | Synonym | Active | Case insensitive | SNOMED CT core |
4964976017 | A rare disorder of pyrimidine metabolism with characteristics of a variable phenotype ranging from absence of symptoms to severe neurological involvement with developmental delay, intellectual disability, and seizures. Additional signs and symptoms may include hypotonia, microcephaly, ocular abnormalities (such as microphthalmia, nystagmus, and strabismus), and autistic behavior, among others. Analysis of urine typically shows high levels of uracil and thymine. Patients are at risk of suffering from severe toxicity after the administration of the anti-neoplastic agent 5-fluorouracil. | en | Definition | Active | Case sensitive | SNOMED CT core |
4964977014 | A rare disorder of pyrimidine metabolism with characteristics of a variable phenotype ranging from absence of symptoms to severe neurological involvement with developmental delay, intellectual disability, and seizures. Additional signs and symptoms may include hypotonia, microcephaly, ocular abnormalities (such as microphthalmia, nystagmus, and strabismus), and autistic behaviour, among others. Analysis of urine typically shows high levels of uracil and thymine. Patients are at risk of suffering from severe toxicity after the administration of the anti-neoplastic agent 5-fluorouracil. | en | Definition | Active | Case sensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dihydrouracil dehydrogenase (NADP^+^) deficiency | Is a | Autosomal recessive hereditary disorder | true | Inferred relationship | Some | ||
Dihydrouracil dehydrogenase (NADP^+^) deficiency | Is a | Enzymopathy | true | Inferred relationship | Some | ||
Dihydrouracil dehydrogenase (NADP^+^) deficiency | Is a | Disorder of pyrimidine metabolism | true | Inferred relationship | Some | ||
Dihydrouracil dehydrogenase (NADP^+^) deficiency | Occurrence | Congenital | false | Inferred relationship | Some | ||
Dihydrouracil dehydrogenase (NADP^+^) deficiency | Finding site | Body system structure | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian emergency department reference set
Clinical finding foundation reference set
Problem/Diagnosis reference set